- Home
- LCTX vs CDRO Comparison
LCTX vs CDRO Comparison
Compare LCTX & CDRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LCTX | CDRO |
|---|---|---|
| Founded | 1990 | 2014 |
| Country | United States | Luxembourg |
| Employees | N/A | 325 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Services-Misc. Amusement & Recreation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 407.7M | 363.1M |
| IPO Year | 1996 | N/A |
Fundamental Metrics
Financial Performance| Metric | LCTX | CDRO |
|---|---|---|
| Price | $1.51 | $8.16 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 1 |
| Target Price | $6.00 | ★ $8.50 |
| AVG Volume (30 Days) | ★ 1.1M | 10.7K |
| Earning Date | 03-05-2026 | 02-28-2023 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $14,556,000.00 | N/A |
| Revenue This Year | $55.75 | $11.31 |
| Revenue Next Year | $2.96 | $6.75 |
| P/E Ratio | ★ N/A | $305.95 |
| Revenue Growth | ★ 53.24 | N/A |
| 52 Week Low | $0.37 | $5.18 |
| 52 Week High | $2.09 | $8.75 |
Technical Indicators
Market Signals| Indicator | LCTX | CDRO |
|---|---|---|
| Relative Strength Index (RSI) | 33.23 | 60.81 |
| Support Level | $0.94 | $7.88 |
| Resistance Level | $1.84 | $8.23 |
| Average True Range (ATR) | 0.11 | 0.20 |
| MACD | -0.04 | 0.00 |
| Stochastic Oscillator | 2.06 | 85.56 |
Price Performance
Historical ComparisonAbout LCTX Lineage Cell Therapeutics Inc.
Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Lineage Cell's product candidate is OpRegen, a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, OPC1, an oligodendrocyte progenitor cell therapy for acute spinal cord injuries, and VAC2, allogeneic cancer immunotherapy of antigen-presenting dendritic cells for non-small cell lung cancer, ANP1, an allogeneic auditory neuron progenitor cells transplant for hearing loss, and PNC1, an allogeneic photoreceptor cell transplant for vision loss.
About CDRO Codere Online Luxembourg S.A.
Codere Online Luxembourg SA is an international online casino gaming and online sports betting group focused on providing its customers with a safe and enjoyable online gaming experience. It currently operates in Spain, Mexico, Colombia, and Other countries. where it offers its users the ability to play online casino games and bet on sports events. Online casino offerings include the full portfolio of games typically available in land-based casinos, gaming halls and gambling establishments, such as slot machines, table games, and bingo. Online sports betting involves a user placing a wager on an event at some fixed odds determined by Codere Online. The company derives maximum revenue from Mexico.